相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast
H. N. Hilton et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers
Peter Kabos et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Effects of estrogen on the proportion of stem cells in the breast
Bruno M. Simoes et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
Sara Ricardo et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
H. Raza Ali et al.
BREAST CANCER RESEARCH (2011)
In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis
Veronique Neumeister et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
So Yeon Park et al.
CLINICAL CANCER RESEARCH (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Progesterone induces adult mammary stem cell expansion
Purna A. Joshi et al.
NATURE (2010)
The prognostic significance of single hormone receptor positive metastatic breast cancer: An analysis of three randomised phase III trials of aromatase inhibitors
R. Stuart-Harris et al.
BREAST (2009)
Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression
Koji Morimoto et al.
CANCER SCIENCE (2009)
Understanding Resistance to Tamoxifen in Hormone Receptor-Positive Breast Cancer
Michaela J. Higgins et al.
CLINICAL CHEMISTRY (2009)
Multiple Lineages of Human Breast Cancer Stem/Progenitor Cells Identified by Profiling with Stem Cell Markers
Wendy W. Hwang-Verslues et al.
PLOS ONE (2009)
Tumor-Endothelial Interaction Links the CD44+/CD24- Phenotype with Poor Prognosis in Early-Stage Breast Cancer
Martin Buess et al.
NEOPLASIA (2009)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
The clinicopathologic and prognostic significance of CD44+/CD24-/low and CD44-/CD24+ tumor cells in invasive breast carcinomas
Eleni Mylona et al.
HUMAN PATHOLOGY (2008)
Cancer stem cells: implications for the progression and treatment of metastatic disease
A. K. Croker et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
H. Korkaya et al.
ONCOGENE (2008)
Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts
Kathryn B. Horwitzt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
Gabriella Honeth et al.
BREAST CANCER RESEARCH (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Biologic and clinical characteristics of breast cancer with single hormone receptor-positive phenotype
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients
Lisa K. Dunnwald et al.
BREAST CANCER RESEARCH (2007)
CD44(+)/CD24(-) breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
Carol Sheridan et al.
BREAST CANCER RESEARCH (2006)
Revealing progesterone's role in uterine and mammary gland biology: Insights from the mouse
R Fernandez-Valdivia et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2005)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Expression of luminal and basal cytokeratins in human breast carcinoma
DMA El-Rehim et al.
JOURNAL OF PATHOLOGY (2004)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
